Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield health care technology firm, has announced the launch of the multi-center Clinical Utility and Economic (CLUE) Trial. The trial aims to quantify the frequency with which surgeons alter their original treatment plans after receiving data from Aclarion’s proprietary Nociscan technology. In the CLUE Trial, surgeons will determine their…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here